FY24 Q3 Results Marksans Pharma, a prominent player in the pharmaceutical industry, revealed its robust Q3 and nine-month FY24 results on February 14, 2024. The company showcased impressive growth, with a 22% year-on-year increase in revenue, driven by market share expansion and new product launches across key markets. Additionally, Marksans Pharma bolstered its margin profile, …